Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery to Prevent Diabetic Foot Ulcers

By HospiMedica staff writers
Posted on 07 Nov 2005
A common, minimally invasive procedure could relieve tightness in the Achilles tendon and help prevent ulcer recurrence in diabetic patients, according to a report from the American College of Foot and Ankle Surgeons (ACFAS, Chicago, IL, USA).

The largest tendon in the body, the Achilles, connects the calf muscles to the heel bone. More...
As people age, the tendon naturally tightens. Then diabetes exacerbates the process, as increased blood sugar levels deposit glucose in the collagen of the tendon, reducing its elasticity and making stretching almost impossible.

Foot ulcers are a common complication of diabetes, resulting from neuropathy, which deprives diabetes patients of the ability to feel pressure or pain in the lower extremities.
Any cut, blister, or wound can develop into a diabetic foot ulcer. These wounds can cause tissue and bone infections and can also result in loss of a toe, a foot, or a leg.

"A tight Achilles inhibits ankle movement, forcing diabetic patients to place excessive pressure on the front of the foot,” explained J. Christopher Moore, D.P.M., a foot and ankle surgeon in Ashville (NC, USA). "Pressure normally absorbed by the ankle has to go somewhere else and the forefoot gets most of it, heightening the risk for ulcer development underneath the toe joints.”

According to Dr. Moore, research has shown that surgery to lengthen the Achilles tendon in a diabetes patient can help prevent ulcer recurrence. Lengthening is accomplished by making three small, pinpoint cuts to loosen and stretch the tendon. This helps restore ankle flexibility and relieves forefoot pressure. The procedure allows diabetes patients who keep their blood sugar under control to walk more normally and may lower their risk for redeveloping foot ulcers.



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.